NEONC Technologies (Neonc)

Oncology Corporate Profile

HQ Location

8335 Sunset Bl., Suite 240
Los Angeles, CA 90069

Company Description

NEONC Technologies, Inc. (NTI) is an early-stage cancer biotechnology company focused initially on intranasal (delivery through the nose) inhalation and other non traditional delivery of a novel, highly purified form of monoterpenes (oils from fruits & plants), alone or with other chemotherapeutic (cancer treatment chemicals) agents.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
NEO-100highly purified perillyl alcoholGlioblastoma Multiforme (GBM)I


Recent News Headlines

There are no news items to display